Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 466,602 shares at $18.75 ($8.3M) on 2018-10-04, disclosed to the SEC on 2018-10-09.
Open-market sale of $8.3M IRWD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.94 | 94,456 | $1.7M | 20.4% |
| 2 | $17.94 | 94,456 | $1.7M | 20.4% |
| 3 | $18.75 | 22,194 | $416K | 5.0% |
| 4 | $18.75 | 22,194 | $416K | 5.0% |
| 5 | $17.53 | 116,651 | $2.0M | 24.6% |
| 6 | $17.53 | 116,651 |
| $2.0M |
| 24.6% |
| Total | $17.81 avg | 466,602 | $8.3M | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |